As of May 29, 2025, Stentys SA (STNT.PA) reports a ROE (Return on Equity) of -2344.21%.
ROE (Return on Equity) measures how well a company generates profits from shareholders' investments, indicating equity efficiency.
Historical Trend of Stentys SA's ROE (Return on Equity)
Over recent years, Stentys SA's ROE (Return on Equity) has shown a stable trend. The table below summarizes the historical values:
| Date | ROE (Return on Equity) |
|---|---|
| 2019-12-31 | -2344.21% |
| 2018-12-31 | -29.38% |
| 2017-12-31 | -48.28% |
| 2016-12-31 | -46.72% |
| 2015-12-31 | -64.93% |
This slight downward trend highlights how Stentys SA manages its efficiency in generating profits from shareholders' equity over time.
Comparing Stentys SA's ROE (Return on Equity) to Peers
To better understand Stentys SA's position, it's useful to compare its ROE (Return on Equity) against industry peers. Below are selected comparisons:
| Company | ROE (Return on Equity) |
|---|---|
| Stentys SA (STNT.PA) | -2344.21% |
| Theraclion SA (ALTHE.PA) | 5233736.30% |
| IGEA Pharma NV (IGPH.SW) | 508.40% |
| Carmat SA (ALCAR.PA) | 149.81% |
| Mauna Kea Technologies SAS (MKEA.PA) | 130.12% |
| Safe SA (ALSAF.PA) | 101.53% |
Compared to its competitors, Stentys SA's ROE (Return on Equity) is among the lowest compared to peers, which may indicate less effective deployment of shareholders' capital.